2021-09-132021-09-131997Bora, İ. vd. (1997). "Myasthenia gravis following IFN-alpha-2a treatment". European Neurology, 38(1), 68-68.0014-3022https://doi.org/10.1159/000112905https://www.karger.com/Article/Abstract/112905http://hdl.handle.net/11452/21882eninfo:eu-repo/semantics/closedAccessNeurosciences & neurologyAutoimmunityHumansInterferon Alfa-2aMaleMiddle agedMyasthenia GravisArticleA1997XL259000122-s2.0-003078654668683819252802Clinical neurologyNeurosciencesMyasthenia Gravis; Vecuronium; Muscle WeaknessAdultCase reportClinical featureHumanKidney carcinomaMaleMotor unit potentialMyasthenia gravisMyasthenia gravisNeutropeniaPriority journal